Insights and Highlights From the Annual Psychiatric Times World CME Conference
Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.
Source: psychiatrictimes.com
Impacts Questionnaire News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Impacts Questionnaire. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Impacts Questionnaire Today - Breaking & Trending Today
GNW-Adhoc: Idorsia is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023 ()
GNW-Adhoc: Idorsia is committed to further the science of sleep with a symposium and poster presentations at World Sleep 2023 () | aktiencheck.de
Source: aktiencheck.de
Orexin: The New Kid on the Insomnia Block
The newest class of medications to treat insomnia have many advantages.
Source: psychiatrictimes.com
Idorsia launches QUVIVIQ (daridorexant) in Switzerland – a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning
QUVIVIQ™ is indicated for the treatment of adult patients with insomnia, characterized by symptoms present for at least three months and considerable impact on daytime functioningQUVIVIQ,... | June 12, 2023
Source: marketscreener.com
Patients With MS Willing to Exchange Disease Progression for Fatigue Relief
Patients with multiple sclerosis would accept more relapses per year and a decrease in time to disease progression for fatigue relief.
Source: neurologyadvisor.com